Harvard Bioscience, Inc. (HBIO) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 47.48M | 48.23M | 43.8M | 44.97M | 44.9M | 45.12M | 46.79M | 46.43M | 48.15M | 49.04M | 50.49M | 52.62M |
| Cash & Short-Term Investments | 7.1M | 8.61M | 6.82M | 7.44M | 5.55M | 4.11M | 4.57M | 4.05M | 4.25M | 4.28M | 5.34M | 4.32M |
| Cash Only | 7.1M | 8.61M | 6.82M | 7.44M | 5.55M | 4.11M | 4.57M | 4.05M | 4.25M | 4.28M | 5.34M | 4.32M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 14.57M | 16.04M | 12.11M | 11.94M | 13.48M | 14.87M | 12.83M | 12.49M | 15.31M | 16.1M | 14.98M | 16.9M |
| Days Sales Outstanding | 66.38 | 54.56 | 53.72 | 56.55 | 58.58 | 51.88 | 53.01 | 54.75 | 58.3 | 50.79 | 57.83 | 54.8 |
| Inventory | 22.2M | 20.8M | 21.6M | 22.25M | 22.82M | 23.25M | 25.99M | 25.13M | 24.14M | 24.72M | 25.82M | 26.09M |
| Days Inventory Outstanding | 227.41 | 204 | 235.42 | 203.47 | 216.14 | 214.78 | 255.46 | 226.91 | 228.21 | 175.9 | 224.49 | 199.34 |
| Other Current Assets | 3.6M | 2.76M | 3.27M | 3.33M | 3.06M | 2.9M | 3.4M | 4.77M | 4.45M | 3.94M | 4.34M | 5.3M |
| Total Non-Current Assets | 30.46M | 31.85M | 34.19M | 35.12M | 34.9M | 81.53M | 84.45M | 82.48M | 85.01M | 88.33M | 89.25M | 90.28M |
| Property, Plant & Equipment | 11.6M | 4.79M | 12.49M | 12.04M | 12.29M | 11.24M | 11.74M | 9.18M | 8.85M | 8.75M | 8.42M | 8.74M |
| Fixed Asset Turnover | 2.53x | 2.75x | 1.68x | 1.68x | 1.85x | 2.14x | 2.10x | 2.56x | 2.78x | 3.28x | 2.96x | 3.25x |
| Goodwill | 9.37M | 9.56M | 9.53M | 10.15M | 8.96M | 56.32M | 57.44M | 56.63M | 56.7M | 57.06M | 56.22M | 56.77M |
| Intangible Assets | 6.91M | 7.64M | 8.38M | 9.14M | 10.13M | 11.13M | 12.34M | 13.44M | 14.68M | 16.04M | 17.09M | 18.36M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.5M | 0 | 0 |
| Other Non-Current Assets | 2.58M | 9.86M | 3.79M | 3.79M | 3.52M | 2.83M | 2.92M | 3.24M | 4.79M | 2.54M | 7.51M | 6.41M |
| Total Assets | 77.94M | 80.07M | 77.99M | 80.09M | 79.8M | 126.64M | 131.24M | 128.91M | 133.16M | 137.37M | 139.74M | 142.9M |
| Asset Turnover | 0.26x | 0.30x | 0.26x | 0.26x | 0.21x | 0.19x | 0.17x | 0.18x | 0.18x | 0.20x | 0.18x | 0.20x |
| Asset Growth % | -2.33% | -36.77% | -40.57% | -37.87% | -40.07% | -7.81% | -6.08% | -9.79% | -8.53% | -5.5% | -4.95% | -7.97% |
| Total Current Liabilities | 23.86M | 21.96M | 54.4M | 55.2M | 55.6M | 54.96M | 22.75M | 22.62M | 25.68M | 26.54M | 24.2M | 22.94M |
| Accounts Payable | 5.29M | 3.65M | 5.18M | 4.72M | 4.81M | 4.79M | 5.28M | 5.71M | 6.04M | 5.55M | 6.27M | 4.72M |
| Days Payables Outstanding | 47.26 | 42.46 | 53.13 | 43.02 | 45.02 | 43.93 | 54.94 | 54.14 | 54.18 | 41.15 | 47.51 | 40.26 |
| Short-Term Debt | 1.55M | 1.52M | 35.45M | 34.86M | 35.96M | 36.96M | 3.61M | 3.72M | 3.72M | 5.86M | 3.47M | 3.22M |
| Deferred Revenue (Current) | 5.02M | 0 | 4.1M | 3.14M | 3.43M | 3.81M | 0 | 4.01M | 4.39M | 7.71M | 4M | 3.83M |
| Other Current Liabilities | 9.83M | 16.78M | 7.79M | 11.02M | 9.99M | 8.25M | 12.73M | 8.12M | 10.33M | 1.58M | 8.34M | 8.65M |
| Current Ratio | 1.99x | 2.20x | 0.81x | 0.81x | 0.81x | 0.82x | 2.06x | 2.05x | 1.88x | 1.85x | 2.09x | 2.29x |
| Quick Ratio | 1.06x | 1.25x | 0.41x | 0.41x | 0.40x | 0.40x | 0.91x | 0.94x | 0.94x | 0.92x | 1.02x | 1.16x |
| Cash Conversion Cycle | 246.52 | 216.09 | 236.01 | 216.99 | 229.69 | 222.73 | 253.53 | 227.52 | 232.33 | 185.53 | 234.82 | 213.88 |
| Total Non-Current Liabilities | 44.03M | 44.38M | 9.53M | 9.16M | 9.36M | 8.35M | 43.17M | 39.04M | 38.67M | 37.75M | 41.24M | 44.57M |
| Long-Term Debt | 36.21M | 35.87M | 0 | 0 | 0 | 0 | 34.25M | 31.96M | 31.89M | 30.7M | 35.27M | 38.2M |
| Capital Lease Obligations | 6.36M | 6.88M | 7.33M | 7M | 7.23M | 6.38M | 6.71M | 4.71M | 4.56M | 4.79M | 4.42M | 4.65M |
| Deferred Tax Liabilities | 313K | 317K | 733K | 734K | 717K | 710K | 707K | 764K | 772K | 776K | 661K | 667K |
| Other Non-Current Liabilities | 1.15M | 1.31M | 1.46M | 1.43M | 1.42M | 1.25M | 1.5M | 1.61M | 1.45M | 1.48M | 892K | 1.05M |
| Total Liabilities | 67.89M | 66.34M | 63.92M | 64.36M | 64.97M | 63.3M | 65.92M | 61.66M | 64.35M | 64.29M | 65.45M | 67.51M |
| Total Debt | 44.12M | 44.28M | 42.78M | 43.31M | 44.61M | 44.49M | 45.69M | 41.45M | 41.36M | 42.77M | 45.29M | 48.2M |
| Net Debt | 37.02M | 35.66M | 35.97M | 35.87M | 39.06M | 40.39M | 41.12M | 37.4M | 37.11M | 38.49M | 39.95M | 43.88M |
| Debt / Equity | 4.39x | 3.22x | 3.04x | 2.75x | 3.01x | 0.70x | 0.70x | 0.62x | 0.60x | 0.59x | 0.61x | 0.64x |
| Debt / EBITDA | - | 13.51x | 28.13x | 54.21x | - | 25.12x | - | - | - | 20.81x | 53.53x | 19.15x |
| Net Debt / EBITDA | - | 10.88x | 23.65x | 44.90x | - | 22.80x | - | - | - | 18.73x | 47.22x | 17.43x |
| Interest Coverage | -0.07x | -0.36x | -0.17x | -1.85x | -62.33x | 1.69x | -4.25x | -3.38x | -4.97x | -0.39x | 0.36x | -1.23x |
| Total Equity | 10.05M | 13.73M | 14.07M | 15.73M | 14.84M | 63.34M | 65.32M | 67.25M | 68.81M | 73.07M | 74.29M | 75.39M |
| Equity Growth % | -32.28% | -78.32% | -78.46% | -76.6% | -78.44% | -13.32% | -12.07% | -10.8% | -7.44% | 1.18% | 3.21% | -2.73% |
| Book Value per Share | 2.25 | 3.09 | 3.16 | 3.55 | 3.36 | 14.55 | 14.98 | 15.46 | 15.85 | 17.11 | 17.40 | 17.80 |
| Total Shareholders' Equity | 10.05M | 13.73M | 14.07M | 15.73M | 14.84M | 63.34M | 65.32M | 67.25M | 68.81M | 73.07M | 74.29M | 75.39M |
| Common Stock | 447K | 447K | 446K | 445K | 442K | 441K | 436K | 436K | 434K | 434K | 457K | 457K |
| Retained Earnings | -218.13M | -214.71M | -211.86M | -210.63M | -208.35M | -158.01M | -158.03M | -153.23M | -150.3M | -145.6M | -143.79M | -142.55M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -12.31M | -11.67M | -12.44M | -11.7M | -14.36M | -15.67M | -13.06M | -14.87M | -14.77M | -14.19M | -15.28M | -14.05M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |